Clinical Trial Update: Evaluation of the Safety and Tolerability of KH001 in Dentin Hypersensitivity Patients [Phase 1, Phase 2]

View source ↗

Summary

This document reports on a completed Phase 1/2 clinical trial evaluating the safety and tolerability of KH001 in patients with dentin hypersensitivity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dentin Hypersensitivity

Drugs mentioned

• KH001

Snippet

Sponsor: HysensBio Co., Ltd | Conditions: Dentin Sensitivity | Phase 1, Phase 2 | Status: COMPLETED